ICLR

ICON Public Limited Company (NASDAQ:ICLR) is a Dublin-based clinical research organization that was founded in 1990 and went public in 1998. The company provides comprehensive outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device companies worldwide. ICON has grown significantly through strategic acquisitions, most notably its 2021 merger with PRA Health Sciences, which transformed it into one of the world's largest contract research organizations. Today, ICON operates globally with a particular strength in supporting clinical trials from early-phase development through post-market surveillance.